BPCL subsidiary completes full takeover of IBV Brasil for Rs 2,312 Cr

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

BPCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹310.65

prior close

₹313.60

announcement price

After-mkt

timing

Nifty 100market+0.3%-1.2% vs market

Refineries & Marketing peers, median of 12sector-0.1%-0.8% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty 100 and 0.8 pts less than its Refineries & Marketing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

-1.3

15m

-1.5

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9+0.3-1.2-0.1-0.8

Next day

-0.8+0.9-1.7-0.3-0.4

+0.8+0.7+0.1-0.1+0.9

-2.3-1.4-0.9-2.1-0.2

-0.7-1.0+0.3-1.6+0.9

-0.1+0.1-0.2-0.8+0.7

-1.7-0.6-1.2-2.3+0.6

15d

-0.2-1.5+1.3-3.1+2.9

+5.1+2.6+2.5-0.3+5.4

+3.0-0.9+3.9-3.8+6.8

-4.4-6.3+1.9-6.7+2.3

UpDownMarket · Nifty 100Sector · Refineries & Marketing peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

BPCL's indirect subsidiary BPRL Ventures BV bought the remaining 39.14 percent stake in IBV Brasil Petroleo Limitada, raising its holding to 100 percent. IBV holds oil and gas exploration interests in Brazil. The all-cash deal cost about Rs 2,312 Crores and was completed on July 1, 2026. Approvals from DIPAM and NITI Aayog were secured. The acquisition gives BPCL fuller access to overseas equity oil and gas, supporting India's energy security. IBV had nil turnover in 2023, 2024 and 2025.

Likely market impact

Strengthens BPCL's overseas upstream footprint, though nil current revenue from IBV limits near-term earnings impact.